PYRAMID Laboratories, Inc.

Article

Sponsored Content

PYRAMID Laboratories, Inc. is located in Southern California, United States. Our facilities are housed in three buildings coverings more than 70,000 ft. The combination of our manufacturing facilities and state-of-the-art laboratory allows PYRAMID to offer the pharmaceutical and biotech industry both analytical and manufacturing support capabilities.

PYRAMID Laboratories, Inc.
3598 Cadillac Avenue, Costa Mesa, CA 92626
Info@pyramidlabs.com
tel. 714.435.9800
fax 714.435.9585

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

MMS Acquires Exploristics and Its Flagship Modeling and Simulation Platform

Patrick Lavery
February 14th 2025
Article

In seeking a data-driven approach to efficient drug development, MMS aims to enhance its capabilities in advanced clinical trial design, innovative statistics, and data science with the acquisition.

Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Axplora Announces €50 Million Investment in GLP-1 Manufacturing in France

Patrick Lavery
February 13th 2025
Article

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Young female tech or scientist performs protein assay | Image Credit: © tilialucida - stock.adobe.com

Leaving STEM Skills on the Table

Susan Haigney
February 13th 2025
Article

Investing in STEM programs for girls in an education setting and then supporting women as they excel in their professional careers is key to ensuring that vital highly skilled personnel are not left behind.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

European Commission Approves BridgeBio Treatment for ATTR-CM

Patrick Lavery
February 12th 2025
Article

Acoramidis was approved by FDA in November 2024 and is prescribed in the US under the brand name Attruby.